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BACKGROUND Patients with diabetes and multivessel coronary ar-
tery disease treated with multivessel percutaneous coronary inter-
vention (MVPCI) have higher mortality, non-fatal myocardial
infarction and repeat revascularization rates compared to coronary
artery bypass graft surgery (CABG). Our study objective is to assess the
trend of MVPCI with stent placement in diabetic patients.
METHODS Data were obtained from nationwide inpatient sample
from 2006-2012, which is a 20% stratiﬁed probability sample of dis-
charges in all community hospitals participating in Healthcare Cost
and Utilization Project. International Classiﬁcation of Diseases 9 codes
were used to identify diabetic patients who underwent percutaneous
coronary intervention with stents in two or more vessels. Patients
who had history of CABG, cardiac transplant, missing data, or
were <18 years old were excluded. Trend analysis was performed on
the number of MVPCIs.
RESULTS A total of 41,586 patients underwent MVPCI between 2006
and 2012. The mean age of the patients undergoing MVPCI was
65.211.46 years. There were 59.89% males and 40.11% females. The
trend analysis showed that incidence of MVPCI in diabetics decreased
by 40.49% from a peak of 8179 in 2006 to 4867 in 2012 (Figure). Drug
eluting stents were used in 78% patients, while non-drug eluting
stents were used in 15.4% patients, and 6.6% of the patients received
both.CONCLUSIONS There was a signiﬁcant decrease in the number of
MVPCI procedures performed on diabetic patients with multivessel
coronary artery disease between year 2006 and 2012.
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BACKGROUND Unprotected left main coronary artery (ULMCA)
stenting has been performed as an alternative to coronary artery
bypass grafting (CABG). However, beneﬁts of percutaneous coronary
intervention (PCI) in patients with ULMCA disease and reduced left
ventricular ejection fraction (LVEF) have not been established.
METHODS We identiﬁed 364 patients with left ventricular systolic
dysfunction (LVEF less than 45%) who underwent left main coronary
revascularization by PCI and CABG from IRIS-MAIN registry (total 4253
patients) between February 2003 and June 2014. The primary end point
was a major adverse cardiac or cerebrovascular event (MACCE), which
was composite of all cause of death,myocardial infarction, target vessel
revascularization or cerebrovascular event, were compared between
those undergoing PCI (n¼137) and CABG (n¼227) at 1 year follow-up.
RESULTS Mean age was 66.711.6 years and 65.08.8 years in the PCI
and CABG groups, respectively (p¼0.17). Male made up 77% and 81%
(p¼0.37). The 1-year incidence of MACCE was similar between two
groups (PCI: 18.8% vs. CABG: 13.0%, p¼0.16). In addition, death (11.9%
vs. 9.8%, p¼0.30), MI (0.9% vs. 0.5%, p¼0.68) and target vessel
revascularization was not signiﬁcantly different (PCI: 5.2% vs. CABG:
1.9%, p¼0.13). After adjustment, the hazard ratio was 1.40 (95% con-
ﬁdence interval [CI]: 0.71 – 2.79, p¼0.33); for all cause of death; 2.37
(95% CI: 0.64 – 8.75, p¼0.20) for target vessel revascularization; 1.49
(95% CI: 0.85 – 2.62, p¼0.16) for MACCE.
Table 1. Incidence of Clinical Outcomes at 1 YearClinical Outcomes PCI (N[137) CABG (N[227) P valueMACCEy 25 (18.8%) 29 (13.0%) 0.160
Death 18 (11.9%) 22 (9.8%) 0.301Cardiac death 11 (8.3%) 14 (9.3%) 0.204Myocardial Infarction 1 (0.9%) 1 (0.5%) 0.678Any Repeat Revascularization 7 (5.1%) 5 (2.2%) 0.145Target Vessel Revascularization 6 (4.3%) 4 (1.9%) 0.127Cerebrovascular event 2 (1.5%) 4 (1.9%) 0.846yThe composite of all cause of death, myocardial infarction, target vessel revascularization and cerebro-
vascular event
